Coherus Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	115.24	88.88	125.99	102.89	63.55	417.2
Short-Term Investments	51.81	83.25	-	14.86	128.13	-
Cash & Short-Term Investments	167.05	172.13	125.99	117.75	191.68	417.2
Cash Growth	102.70%	36.62%	7.00%	-38.57%	-54.05%	-22.91%
Accounts Receivable	22.51	18.42	122.33	260.52	109.96	123.02
Inventory	4.83	3.17	4.21	62.61	38.79	37.64
Other Current Assets	11.65	12.99	89.06	34.76	40.8	24.46
Total Current Assets	206.04	206.71	341.58	475.63	381.23	602.32
Net Property, Plant & Equipment	1.09	1.35	2.58	5.12	8.75	7.81
Other Intangible Assets	45.61	46.24	53.65	71.67	5.93	3.56
Goodwill	-	-	-	-	-	3.56
Other Long-Term Assets	13.28	4.05	50.73	77.18	84.93	65.64
Total Assets	266.02	258.34	448.53	629.6	480.85	679.33
Accounts Payable	11.48	9.92	28.46	35.22	11.53	16.16
Accrued Expenses	120.85	130.47	254.53	296.55	127.17	149.17
Total Current Liabilities	132.33	140.39	282.98	331.77	138.69	165.33
Long-Term Debt	37.15	37.05	264.93	473.37	471.06	408.28
Long-Term Leases	0.95	1.46	3.29	5.33	5.05	7.25
Other Long-Term Liabilities	16.97	18.44	29.33	12.56	3.47	0.75
Total Long-Term Liabilities	55.07	56.94	297.54	491.26	479.57	416.28
Total Liabilities	187.4	197.33	580.52	823.03	618.27	581.61
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,500	1,444	1,419	1,386	1,204	1,148
Accumulated Other Comprehensive Income	-0.27	-0.2	-0.28	-0.25	-0.25	-0.27
Retained Earnings	-1,421	-1,383	-1,551	-1,580	-1,342	-1,050
Shareholders' Equity	78.62	61.01	-131.99	-193.43	-137.42	97.73
Total Liabilities & Equity	266.02	258.34	448.53	629.6	480.85	679.33
Total Debt	38.1	38.51	268.21	478.7	476.1	415.53
Net Cash (Debt)	128.95	133.62	-142.23	-360.95	-284.42	1.66
Net Cash Growth	-3.50%	-	-	-	-	-98.69%
Net Cash Per Share	1.05	1.14	-1.24	-3.83	-3.66	0.02
Book Value	78.62	61.01	-131.99	-193.43	-137.42	97.73
Book Value Per Share	0.64	0.52	-1.15	-2.05	-1.77	1.30
Tangible Book Value	33.01	14.78	-185.64	-265.1	-143.35	90.6
Tangible Book Value Per Share	0.27	0.13	-1.62	-2.82	-1.85	1.20

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q